ADORA2A and neoplasm: While T cell proliferation is only marginally affected by A2AR activation [80], effector CD8+ T cell cytotoxicity and cytokine production are significantly diminished, indicating that T cells retain proliferative capacity but lose tumor cell elimination ability.